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Abstract
Background: Notch and Wnt pathways are key regulators of intestinal homeostasis and alterations in these pathways may
lead to the development of colorectal cancer (CRC). In CRC the Apc/b-catenin genes in the Wnt signaling pathway are
frequently mutated and active Notch signaling contributes to tumorigenesis by keeping the epithelial cells in a proliferative
state. These pathways are simultaneously active in proliferative adenoma cells and a crosstalk between them has previously
been suggested in normal development as well as in cancer.
Principal Findings: In this study, in silico analysis of putative promoters involved in transcriptional regulation of genes
coding for proteins in the Notch signaling pathway revealed several putative LEF-1/TCF sites as potential targets for b-
catenin and canonical Wnt signaling. Further results from competitive electrophoretic mobility-shift assay (EMSA) studies
suggest binding of several putative sites in Notch pathway gene promoters to in vitro translated b-catenin/Lef-1. Wild type
(wt)-Apc negatively regulates b-catenin. By induction of wt-Apc or b-catenin silencing in HT29 cells, we observed that
several genes in the Notch pathway, including Notch-2, were downregulated. Finally, active Notch signaling was verified in
the Apc
Min/+ mouse model where Hes-1 mRNA levels were found significantly upregulated in intestinal tumors compared to
normal intestinal mucosa. Luciferase assays showed an increased activity for the core and proximal Notch-2 promoter upon
co-transfection of HCT116 cells with high expression recombinant Tcf-4, Lef-1 or b-catenin.
Conclusions: In this paper, we identified Notch-2 as a novel target for b-catenin-dependent Wnt signaling. Furthermore our
data supports the notion that additional genes in the Notch pathway might be transcriptionally regulated by Wnt signaling
in colorectal cancer.
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Introduction
The epithelium of the gastrointestinal tract is continually
replaced with a turn-over rate of two to seven days. In order to
maintain homeostasis of the intestinal epithelium, processes
cellular proliferation, differentiation, migration and death must
be strictly regulated [1–3]. A few but highly conserved signaling
pathways are thought to drive these processes (reviewed in [4,5]
and [6]). The canonical Wnt signaling pathway was the first to be
discovered as being essential for intestinal crypt cell proliferation
and homeostasis [7–10]. One central component of this pathway is
the cytoplasmic protein b-catenin, which when translocated into
the nucleus as a result of Wnt signals, serves as a co-factor for
transcription factors of the Lef-1/Tcf (Lymphoid enhancer factor-
1/T Cell Factor) family to allow for activation of a downstream
genetic program [11]. The level of b-catenin in the colon
epithelium is regulated by the ubiquitinin-proteasome system
[12]. One of the critical components of the b-catenin destruction
complex is the adenomatous polyposis coli (Apc) protein [11].
Mutational inactivation of this gene causes stabilization of b-
catenin [13] and increased cell proliferation and represents one of
the most common genetic alterations in colorectal cancer (CRC)
[14]. This results in increased levels and nuclear translocation of b-
catenin and subsequent dysregulated activation of LEF-1/TCF
target genes [5].
The maturation of intestinal stem cells is also regulated by the
Notch signaling pathway representing another evolutionary
conserved signaling system involved in maintaining colon
epithelium homeostasis [2–4,15–17]. Core elements in this
signaling pathway are the monomeric transmembrane bound
Notch receptors (Notch1–4 in mammals), which upon binding to
ligand (Deltalike-1, -3, -4, Jagged-1 or -2) release an intracellular
domain (NICD) that serves as a transcriptional co-factor. The
specificity of ligand/receptor interaction is determined through
addition of sugar moieties by the glycosyltransferases from the
Fringe gene family (Lunatic fringe, Lfng; Maniac fringe, Mfng and Radical
fringe, Rfng) [18–20]. NICD translocates into the nucleus to form a
transcriptional activation complex with the DNA-binding factor
CSL (Rbp-jk) and co-activators belonging to the Mastermind-like
family (Maml) [15,21,22]. Some of the best-characterized targets of
this transcriptional activation complex belong to the Hes -and Hey
family of genes, which function as transcriptional repressors of
further downstream targets like Math-1 (mouse homolog of human
Hath-1) [23–25]. It has been suggested that Notch-1 and Notch-2
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activation through either of these receptors is sufficient to prevent
differentiation of proliferative crypt progenitor cells into post-
mitotic goblet cells, indicating that Notch signaling could be
predisposing for malignant transformation [2]. This has been
associated with derepression of the cyclin-dependent kinase
inhibitors p27
Kip1 and p57
Kip2 [2] as well as upregulation of
Math-1 mRNA and protein [2,26,27]. However, Notch-2 has also
been proposed to have a tumor suppressive effect in CRC [28],
suggesting complex, possibly stage related, functions of Notch
signaling in the intestine.
In addition to the independent roles of Wnt and Notch
signaling pathways in tumorigenesis in the colon, the findings
that tumor development in Apc-deficient mice is enhanced upon
simultaneous activation of Notch and Wnt signals [29] and that
many intestinal tumors display abnormal activation of both
pathways [3] suggest a molecular interplay between Notch and
Wnt signaling in the formation of CRC. Despite the apparent
importance of this crosstalk and that coordinated actions have
been reported at different levels [30], little is known about the
molecular mechanisms linking these pathways in the intestinal
epithelium. It has been shown that Hath-1 expression is
increased when the Wnt pathway is inhibited [26] and that
Hes-1 is a direct target of canonical Wnt signaling in colorectal
adenomas and carcinomas [29,31] Furthermore, Jagged-1 has
been shown to represent a molecular link between Wnt and
Notch in CRC, where the Jagged-1 gene is directly regulated by
b-catenin/Tcf-4 [32]. The interactions between Wnt and Notch
in CRC, and the results thereof, are not fully understood and
the results from different studies are often diverging [3,31]. This
emphasizes the complexity of the crosstalk and suggests that it
may not simply be a matter of shared downstream targets of the
pathways.
In this study, we have investigated the potential of the Wnt
signaling pathway for direct regulation of genes involved in Notch
signaling. This revealed that several of the putative promoter
regions in Notch pathway associated genes contain Lef-1/Tcf-
binding sites. Some of these genes were downregulated upon
expression of a functional Apc gene in the HT29 CRC cell line,
supporting the idea that abnormal Wnt signaling has a direct
impact on the expression of genes encoding proteins involved in
Notch signaling. Thus, we propose that crucial components of the
Notch signaling pathway are directly influenced by Wnt signaling
with the implication that even a genetically normal Notch pathway
can contribute to tumorigenesis due to the response to b-catenin or
Apc mutations.
Results
Promoter sets and in silico identification of potential
LEF-1/TCF-sites in Notch pathway promoters
To identify potential targets for interactions between the Notch
and Wnt signaling pathways, 65 genes, known to be important for
Notch and Wnt signaling, were selected bioinformatically using
the Ingenuity Pathways Analysis (IngenuityH Systems, www.
ingenuity.com), together with extensive literature searches. Gene
promoter sequences were extracted using the Genomatix Gene2-
Promoter software and the average length of the putative core,
proximal and parts of the distal promoters were adjusted to
approximately 2500 bp (details available on request). By means of
the MatInspector software [33] the promoter sets for putatitve
LEF-1/TCF sites were identified with the putative consensus
sequences: 59-(A/T)(A/T)CAA(A/T)G-39 [34]. Twenty-four of
the investigated genes in the Notch pathway were found to contain
one or several putative LEF-1/TCF sites (Fig. 1 and Supplemental
Information S1).
Thus, in silico analysis of the genetic networks involved in Notch
and Wnt signaling supports the previously shown interactions with
Hes-1 [31] and Jagged-1 [32] and, furthermore, suggests a direct
crosstalk via target gene activation on several additional levels in
the Notch pathway.
The b-catenin/Lef-1-complex binds in vitro to Notch
pathway gene promoters
To determine whether the in silico identified LEF-1/TCF
binding sequences physically bind to the b-catenin/Lef-1 complex
in vitro, we conducted a competitive electrophoretic mobility-shift
assay (EMSA) with a radioactively labeled consensus LEF-1/TCF
strong binding probe (CD1TOP [35]) and duplex oligonucleotides
covering the potential sites in target promoters. Notch pathway
EMSA promoter probes (Table S1) were tested against an in vitro
translated Lef-1/ß-catenin complex.
To confirm that radioactively labeled CD1TOP binds Lef-1
specifically, plasmid-free reticulocyte lysates were subject to in vitro
translation and incubated with a radiolabeled probe. As expected,
no binding was observed (Fig. 2). All of the investigated Notch gene
promoters, Notch-2, Jagged-1, Maml-1, Hes-1, Rfng, Lfng and Numbl,
showed binding of at least one putative LEF-1/TCF site in their
promoter regions identified in silico (Fig. 2) (additional competitive
EMSA results are found in Fig. S1). To our knowledge Notch-2,
Maml-1, Rfng and Lfng are new potential Wnt target genes not
described previously. Two of the strongest binding sites were
Figure 1. In silico analysis of Notch pathway gene promoters. In
silico analysis of the genetic networks directly involved in Notch and
Wnt signaling suggest overlap and direct crosstalk via Notch target
gene activation through canonical Wnt signaling. By means of
MatInspector, [33] gene promoters in the Notch pathway were found
to contain at least one putative LEF-1/TCF-site (number of sites in per
gene is described in square brackets). Genes in gray boxes were
subjected for further semi quantitative RT-PCR analysis.
doi:10.1371/journal.pone.0017957.g001
Notch and Wnt Regulation in Colorectal Cancer
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17957found in the Jagged-1 promoter at 21933 and 21635 relative to
the translation start site, which is in accordance with earlier studies
where Jagged-1 has been shown to be a b-catenin/Tcf-4 regulated
gene in human CRC [32] as well as in mouse hair follicles [36].
Hes-1 has recently also been identified as a direct transcriptional
target of b-catenin/Tcf-4-dependent Wnt signaling in CRC [31]
and our EMSA data supports this notion by clearly identifying
Hes-1 -528 as a binding site for the b-catenin/Lef-1 complex
(Fig. S1).
The results from both the in silico and DNA binding analyses
suggest that a transcriptional network links the Wnt and Notch
pathway, implying a functional regulation of canonical Wnt
signaling at several levels of the Notch pathway.
Canonical Wnt signaling regulates Notch pathway genes
in HT29 colorectal cancer cell line and murine intestinal
adenomas
Mutational inactivation of the Apc gene is a key event in
colorectal carcinogenesis and renders constitutive active Wnt
signaling [13,14]. In order to develop the in silico and DNA
binding analyses and functionally investigate the effects of
activated Wnt signaling on Notch pathway genes, nineteen genes
in the Notch pathway, known to be important for canonical Notch
signaling (Fig. 1 and Table S1), containing putative LEF-1/TCF-
sites, were selected for further studies with semi-quantitative RT-
PCR. To activate wt-Apc and thereby restricting the levels of
nuclear b-catenin, a HT29 cell line carrying a Zn-inducible wt-
Figure 2. In vitro translated b-catenin/Lef-1 binds to Notch pathway gene promoters. Competitive electro mobility-shift assay of the
proximal Notch-2 promoter. Duplex CD1TOP probes were ‘‘end labeled’’ with [
32P]dATP, incubated with in vitro translated b-catenin/Lef-1 and
exposed to competition with abundance of cold or cold mutated promoter duplex oligonucleotides (6300 and6900, respectively). The protein-DNA
complexes were separated by electrophoresis and visualized by autoradiography. As a competition control cold CD1TOP and cold mutated CD1FOP
competed with radiolabeled CD1TOP and to confirm that radioactive labeled CD1TOP binds Lef-1 specifically, plasmid-free reticulocyte lysate were
subjected to in vitro translation and incubated with radiolabeled probe. Gene numbering describe position of the LEF-1/TCF-site relative the gene
translation start site. Adjustments in whole image contrast levels were performed in Adobe Photoshop CS4.
doi:10.1371/journal.pone.0017957.g002
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levels in HT29-APC, 6–24 h post Zn
2+-stimulation, but not in
HT29-b-gal cells (Fig. 3A). The 19 Notch pathway genes were
analyzed by semi-quantitative RT-PCR and Hes-1, Hes-7, Notch-2,
Maml-1, Lfng, Rfng, Numb and Numbl were found to be
transcriptionally downregulated, while the negatively regulated
gene Hath-1 was clearly upregulated 18–24 h post wt-Apc
induction (Fig. 3B). As a positive control, the cyclin D1-gene
expression, induced by b-catenin [37], was downregulated 6–24 h
post Zn-induction, confirming inhibition of the Wnt pathway via
expression of wt-Apc and reduced b-catenin levels. The results are
in concordance with previous studies where b-catenin protein
levels have been found to be downregulated [38] and the b-
catenin/hTcf-4 nuclear complex reduced [39] upon Zn-stimula-
tion in HT29-APC cells indicating, decreased levels of nuclear b-
catenin. Interestingly, we could not detect any influence of Wnt
signaling and wt-Apc expression on Jagged-1 in HT29 cells even
though a confirmed specific binding of CD1TOP to in vitro
translated Lef-1 was displaced with a 300-fold excess of cold
Jagged-1 21933 and 21635 probes but not with their mutated
Figure 3. The expression of Notch pathway genes are dependent of Apc status in HT29 cells and murine intestinal adenomas. Wt-Apc
was induced in HT29-APC cells through the addition of 100 mM ZnCl2 to the growth medium. Semi-quantitative RT-PCR was carried out on cDNA
reversely transcribed from 200 ng total RNA from each time point (0–24 h post wt-Apc induction). Bars describe the relative expression of Notch-2 in
HT29-APC cells (*) versus HT29-b-galactosidase cells (**) normalized against Gapdh expression. Cyclin D1 was used as a positive control for Wnt
inactivation. (B) The protein expression of Apc (,310 kDa), Notch-2 (,265 kDa), wt and loading control, Gapdh, was determined with Western blot
following 0–24 h of zinc stimulation. Adjustments in whole image contrast levels were performed in Adobe Photoshop CS4. (C) Relative mRNA
expression of murine Notch-1, Notch-2 and Hes-1 in tumors and corresponding non-tumor normal intestinal mucosa of Apc
Min/+ mice. mRNA
expression was related to the endogenous control gene GAPDH. White columns (n=16), black columns (n=22). Bars are presented as median
expression values. Error bars describe interquartile range.
doi:10.1371/journal.pone.0017957.g003
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Notch pathway genes, by wt-Apc, are directly under control of b-
catenin, we performed anti-b-catenin siRNA silencing experiments
(Fig. S2), using a pool of four different siRNAs targeting b-catenin.
In general, downregulation was less significant than Zn induced
decrease in Notch-2, Numb and Numbl (Fig. 2A), displaying a weak
but consistent decrease in their respective mRNA levels. Hes-1 was
clearly downregulated 72–96 h post transfection, corroborating
the findings by Peignon et al. [31]. Rfng and Lfng were not affected
by b-catenin silencing indicating that their downregulation by Wnt
signaling observed in Fig. 3B may not be a direct effect of b-
catenin induced transcription used in this experimental setup.
Cyclin D1 was used as a positive control for the siRNA experiments
and was clearly downregulated 72–96 h post transfection. To test
more long-term effects of deregulated Wnt signaling in intestinal
epithelium we analyzed Notch-1, Notch-2 and Hes-1 mRNA
expression levels in Apc
Min/+ mice (Fig. 3C) carrying a germline
truncating heterozygous mutation at codon 850. The mRNA
levels of mHes-1 were found to be significantly upregulated in
adenomas (median relative expression=2.0, interquartile
range=1.5–2.4) compared to normal intestinal mucosa (median
relative expression=1.5, interquartile range=0.9–1.7) (Mann-
Whitney U-test, p=0.013), indicating overactivated Notch signal-
ing in the mouse adenomas. A trend towards upregulation was
observed for mNotch-2 in tumor tissue (median relative expres-
sion=1.6, interquartile range=1.0–2.0) compared to normal
intestinal mucosa (median relative expression=1.3, interquartile
range=0.9–1.8) (Mann-Whitney U-test, p=0.14), while no
statistically significant differences could be detected for mNotch-1
(median relative expression=3.9, interquartile range=2.5–5.7
(tumor tissue)) vs. (median relative expression=3.8, interquartile
range=2.4–5.3 (normal tissue)) (Mann-Whitney U-test, p=0.9).
In conclusion, inactivation of the Wnt pathway through
activation of wt-Apc in HT29 CRC cells downregulates several
target genes in the Notch pathway while mRNA-levels of the
Notch target mHes-1 is significantly upregulated in intestinal
tumors from Apc deficient mice. This further supports a direct
transcriptional crosstalk suggested by the in silico and in vitro DNA-
binding analyses.
The in silico identified Notch-2 promoter contains four
putative LEF1/TCF-sites and contributes to a high
luciferase gene activity
Notch-2 functions redundantly with Notch-1 in colon epithelial
cells where both genes are important for keeping the cells in the
crypt compartment in a proliferative and undifferentiated state [2].
However, relatively little is known about transcriptional regulation
of the Notch genes and a potential regulation of Notch-2 through
Wnt signaling could be of importance in the development and/or
progression of CRC and potentially in other malignancies as well.
Previously, it has been shown that both Hes-1 and Jagged-1 are
direct targets of canonical Wnt signaling in CRC [31,32]. Our
results from in silico, in vitro DNA-binding analyses and activation of
wt-Apc, strongly suggest that there is a direct positive regulation of
Notch-2 through Wnt-signaling. Therefore we wanted to further
elucidate the b-catenin/Lef-1/Tcfs regulating potential of the
Notch-2 promoter in the CRC cell lines HT29 and HCT116.
As described above, in silico analyses were used to identify the
human Notch-2 promoter and a potential transcriptional start site
(TSS) was found 256 bp upstream the translational start site,
verifying the result from Gene2Promoter analysis. Four putative
LEF-1/TCF consensus sites were identified in the core and
proximal promoter region at positions 22261, 2869, 2689 and
2110 relative to the translational start site (Fig. 4A). The 2110
site showed strong binding to Lef-1 in the in vitro DNA binding
competitive EMSA assay while sites 22261 and 2689 showed
weak binding (Fig. 2).
To analyze the Notch-2 promoter, we focused on the 2200
nucleotide region spanning both the 59 and 39 regions of the Notch-
2 putative transcriptional start site. Two separate constructs were
generated, one spanning from position 22327 to 299 (N2PR
22327/299) (numbers relative to translational start site), thereby
covering all four putative LEF-1/TCF-sites and one covering
putative LEF-1/TCF-site 2110. They were cloned into a firefly
luciferase reporter vector (pGL3 Luciferase reporter vector,
Promega) containing a TATA-box to detect possible enhancer
and repressor cis-acting elements (described previously [40]). The
constructs were transiently transfected into HCT116 or HT29
cells and reporter gene activities were measured at 24 hours post
transfection. Promoter activity was enhanced 13-fold for N2PR
22327/299 vs. 1.7-fold for N2PR 2110 promoter construct
compared to the background in HCT116 cell lines (p,0.007 vs.
p=0.04, n=6 (Fig. 4B)). The luciferase assay shows that the
cloned region of the putative Notch-2 promoter contains enhancer
elements leading to enhanced transcription of the luciferase gene.
These results strongly suggest the location of the core, the
proximal part and parts of the distal Notch-2 promoter as identified
by the in silico analysis.
Overexpression of b-catenin, Lef-1 or Tcf-4 result in
increased Notch-2 promoter activity
Notch-2 mRNA and protein levels are clearly downregulated 18–
24 h post Zn-induction of wt-Apc in HT29-cells (Fig. 3B and B).
Notch-2 mRNA expression was also analyzed following RNAi
silencing of b-catenin in HT29 cells where a weaker effect was
observed similar to the other wt-Apc/b-catenin regulated Notch
pathway genes (Fig. S2).
The results from the HT29-APC cell line where Apc was
activated or b-catenin silenced, imply an activating role of the Wnt
pathway on Notch-2 and the downstream target gene Hes-1 [31].
Therefore, we predicted that overactivation of canonical Wnt
signaling through b-catenin/LEF-1/TCF would result in in-
creased Notch-2 promoter activity. To further elucidate the
activation and interactions suggested by the Wnt inactivation
experiment, we subjected HCT116 cells to luciferase assays using
the N2PR 22327/299 and N2PR 2110 promoter constructs. To
study if Wnt signaling effects on Notch-2 are mediated through b-
catenin/Lef-1/Tcf, cells were co-transfected with high expression
vectors (pCGN and pcDNA6) containing S33Y-b-catenin (S33Y
mutation), hTcf-4 or mLef-1 sequences and the relative luciferase
activity was calculated by normalizing Notch-2 promoter activity
(N2PR 22327/299 or N2PR 2110) vs. pGL3-TATA-activity.
Western blots confirmed expression of His-tagged Tcf-4 and Lef-1
(Fig. 5D). Relative luciferase activity was significantly increased for
co-transfection with S33Y-b-catenin, both for N2PR 22327/299
as well as N2PR 2110 with a fold increase of 5.2 for N2PR
22327/299 (p=0.007) and 1.8 for N2PR 2110 (p,0.0001)
compared to the pcDNA6 co-transfection (5A, B and Supplemen-
tal Information S1). The increase in N2PR 2110 activity upon co-
transfection with mutated b-catenin was confirmed in HT29 (1.6-
fold, p=0.03) (Fig. S3). The results imply that b-catenin has the
ability to activate the core and proximal Notch-2 promoter. Tcf-4
and Lef-1 also enhance the N2PR 22327/299 activity construct
(2.0 fold increase (Tcf-4) (p=0.02) and 2.8 (Lef-1) (p=0.001),
respectively. However, the increase in activity was not as
significant as that seen upon b-catenin co-transfection, indicating
more specific effects of the DNA-binding proteins. Tcf-4 and Lef-1
failed to significantly affect the activity of N2PR 2110 and no
Notch and Wnt Regulation in Colorectal Cancer
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construct, where the putative LEF1/TCF site at position 2110
was mutated into a SpeI restriction site. These results suggest that
LEF1/TCF consensus site 2110 is not a direct target of canonical
Wnt signaling in this system through Tcf-4 or Lef-1 (Fig. 5B).
However, contrasting this, competitive EMSA at the Notch-2 LEF-
1/TCF 2110 site displayed specific binding to in vitro translated b-
catenin/Lef-1 (Fig. 2), where 300-fold excess of cold but not
mutated 2110 probe displaced the interaction between CD1TOP
and in vitro translated Lef-1. Notch-2 22261 and 2689 sites only
competed weakly with CD1TOP binding to in vitro translated Lef-
1 compared to their mutated variants and were these therefore
excluded from the ChIP analysis. In addition to EMSA, we
examined the DNA-protein binding between Lef-1 or Tcf-4 and
the Notch-2 promoter in HCT116 cells transfected with recombi-
nant His-tagged Lef-1 or Tcf-4 by ChIP. To increase the
sensitivity, cells were co-transfected with N2PR 22327/299
and N2PR 2110 luciferase constructs. Western blots with 66His
tagH antibody confirmed efficient transfection of His-tagged Lef-1
and Tcf-4 (Fig. 5D). Following immunoprecipitation and appro-
priate washing steps, harvested DNA was amplified as a short 93-
bp amplicon of the Notch-2 promoter covering LEF-1/TCF-site
2110. We observed successful immunoprecipitation of both Tcf-4
and Lef-1 (Fig. 5C), somewhat contradicting the results from the
site-directed mutagenesis and subsequent luciferase experiment of
site 2110. A 178-bp fragment of the NCAPD2 promoter was used
as a negative control and showed no immunoprecipitation
(Fig. 5C).
Overall, these results suggest that Notch-2 can be transcription-
ally regulated by canonical Wnt signaling, however the exact
mechanism and interactions sites remain to be elucidated.
Discussion
Wnt and Notch signaling pathways are both important
regulators of intestinal homeostasis and play major roles in the
development of CRC [2–4,7–11,14,15,17]. They have been
shown to have synergistic effects in intestinal cell fate decisions
and overactivation of Notch signaling in Apc deficient mice results
in earlier onset and more tumors in the small intestine, compared
to Apc deficient mice alone. However, overexpression of Notch
signaling does not by itself cause intestinal tumor formation in the
Figure 4. The Notch-2 promoter contains four putative LEF1/TCF-sites and results in high luciferase gene activity. (A) Schematic
representation of the proximal Notch-2 promoter with the four putative LEF-1/TCF-binding consensus sites, identified with Genomatix MatInspector,
at positions 22261, 2869, .689 and 2110 relative translational start site (ATG). A potential transcription start site was mapped to position 2256 using
Genomatix Gene2Promoter and PromoterInspector software. Uppercase letters indicate the core consensus sequence. (B) N2PR 22327/299, N2PR
2110 in pGL3-TATA as well as empty pGL3-TATA (Smith et al, 2002 [40]) were transfected into HCT116 and and co-transfected with pSV-b-
galactosidase control vector. The cell lysate 24 h post transfection was subjected to luciferase reporter assays and relative luciferase activity
determined. Error bars describe SEM.
doi:10.1371/journal.pone.0017957.g004
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two pathways [36,41–48] although detailed knowledge regarding
their transcriptional interaction network is relatively scarce. The
results of Notch and Wnt interactions in intestinal adenomas are
complex and most likely context dependent. van Es et al. [3] have
demonstrated that blockage of Notch in the context of overactive
Wnt signaling leads to the differentiation of proliferative mouse
intestinal tumors into post-mitotic goblet cells and reduced tumor
growth, something Peignon et al. [31] failed to corroborate in a
conditional model where both the Apc and RBJ-k genes were
deleted simultaneously, the latter reflecting a model of more acute
Apc loss. In the present study, in silico analysis of Notch and Wnt
pathway gene promoters resulted in the identification of several
putative b-catenin regulated LEF-1/TCF-sites in Notch pathway
gene promoters and RBP-Jk-sites in Wnt pathway gene promoters
(Fig. 1 and Supplemental Information S1). Tissue-specific gene
expression can be predicted from the nucleotide sequence
approximately 1–2 kb upstream (and partly downstream) TSS
[49], and therefore the length of the promoters, further
investigated with the MatInspector software were adjusted to
approximately 2500 bp. Both Lef/Tcfs and Rbp-jk have strong
DNA-binding domains and transcription is activated upon binding
to b-catenin or NICD, respectively [50–54]. Twenty-four of the
investigated gene core and proximal promoters in the Notch
pathway contain at least one putative LEF-1/TCF consensus site
and Hey-2 contains as many as six while 28 of the bioinformatically
investigated genes in the Wnt pathway contain one or more RBP-
Jk-sites (Supplemental Information S1). Recently, Rodilla and co-
workers [32] performed a study where they blocked Wnt signaling
through b-catenin in Ls17T CRC cells using a dominant negative
(dn) Tcf-4 inducible vector and identified transcriptional targets
using microarray mRNA expression profiling and quantitative
RT-PCR. Interestingly, Jagged-1 was identified as one of the most
clearly affected targets and transcriptionally activated by the b-
catenin/Tcf-4-complex. The interaction was verified in vivo
thereby establishing Jagged-1 as a pathological link between Wnt
Figure 5. The Notch-2 promoter is transcriptionally activated via Lef-1/Tcf-4/ß-catenin mediated signaling. (A) HCT116 cells were co-
transfected with pGL3-TATA carrying N2PR 22327/299 (or empty pGL3-TATA) and HA-S33Y-b-catenin in pCGN, hTcf-4 or mLef-1 in pcDNA6 as well
as pSV-b-galactosidase control vector (n=6). (B) HCT116 cells were co-transfected with pGL3-TATA carrying N2PR 2110 (white columns) or mutated
N2PR 2110 SpeI (black columns) (or empty pGL3-TATA) and HA-S33Y-b-catenin in pCGN, hTcf-4 or mLef-1 in pcDNA6 as well as pSV-b-galactosidase
control vector. Luciferase activity was normalized against pGL3-TATA background activity by dividing N2PR 22327/299-pGL3-TATA relative
expression with the relative expression from empty luciferase vector (n=9). Error bars describe SEM. (C) ChIP in HCT116 cells co-transfected with His-
tagged Lef-1 or Tcf-4, N2PR 22327/299 and N2PR 2110; immunoprecipitation with anti-His (66His tagH antibody) or IgG control, PCR with primers
encompassing LEF-1/TCF-site 2110 in the Notch-2 promoter. A 172-bp segment of NCAPD2 promoter was used as a negative control. (D) Western
blots with anti-His (66His tagH antibody) verifying the transfection of His-tagged Lef-1 (,65 kDa) and Tcf-4 (,45 kDa) in HCT116. Adjustments in
whole image contrast levels were performed in Adobe Photoshop CS4.
doi:10.1371/journal.pone.0017957.g005
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knowledge, the putative LEF1/TCF-binding sites in Jagged-1
responsible for this interaction are unknown. The in silico
determined core, proximal and parts of the distal Jagged-1
promoter contains four putative LEF-1/TCF-sites. In this study,
we show that the b-catenin/Lef-1 complex is capable of binding to
the Jagged-1 promoter in vitro at positions 21933, 21635 and
possibly 21083 relative to the translation start site (Fig. 2 and Fig.
S1) making these plausible sites for transcriptional interactions
between Jagged-1 and the canonical Wnt pathway. However, upon
activation of wt-Apc in HT29 CRC cells, no effects on Jagged-1
mRNA levels were detected (Fig. 3B), which could be a result of
different cell lines and study design. In addition to Jagged-1, in vitro
translated b-catenin/Lef-1 was found to bind LEF-1/TCF-sites in
Notch-2, Maml-1, Hes-1, Rfng and Lfng gene promoters. Of these
genes Hes-1 has been shown to be an important direct target of ß-
catenin/Tcf-4 mediated Wnt signaling in CRC [31], which our
data confirms. A HT29 (lacking wt-Apc) cell line carrying a Zn-
inducible wt-Apc [39] vector was used to regulate the b-catenin
levels and usually wt-Apc was detected with Western blot analysis
after 6 h of zinc stimulation (Fig. 3A), compared to a similar HT29
cell line carrying a Zn-inducible b-galactosidase vector.
Using semi-quantitative RT-PCR, we found Notch-2, Maml-1,
Hes-1, Hes-7, Rfng, Lfng, Numbl, and Numb, as well as controls like
cyclin D1 and Hath-1 to be transcriptionally up/downregulated
after Zn-induced Apc expression (Fig. 3B). As expected Hath-1
mRNA levels were upregulated synchronously with Hes-1
downregulation, further supporting Wnt signaling effects on Notch
–and Notch downstream mediators. Several of these genes may be
regulated through canonical Wnt signaling but upon silencing of
b-catenin, the downregulation of expected target genes was less
significant compared to the wt-Apc induction, which may be
explained by incomplete inhibition by the siRNA treatment (Fig.
S2A). It is also possible that the kinetics is different for a direct b-
catenin inhibition compared to wt-Apc induction, where several
additional factors like mRNA-degradation and stability may affect
the mRNA levels. In order to investigate this future studies are
warranted. In accordance with the results of Peignon et al. [31]
Hes-1 mRNA levels were found upregulated in intestinal tumors
from Apc deficient mice compared to normal intestinal mucosa.
The authors also reported significantly higher levels of Notch-1 and
Notch-2 in the murine tumors, something we failed to corroborate
even though Notch-2 mRNA levels possibly follow this trend
(Fig. 3C). Differences might be explained by the use of different
models. Their mice mainly develop colonic polyps whereas the
Apc
Min/+ model mostly generates tumors in the small intestine.
Apc
Min/+ mice are heterozygous for the Apc gene, which may lead
to heterogenous b-catenin activation, which might obscure the
effects on the Notch target genes.
Notch-2 mRNA and protein levels were found to be downreg-
ulated upon wt-Apc induction in HT29 cells (Fig. 3B and B) and
results from b-catenin siRNA silencing implied that Wnt signaling,
at least partially, affects Notch-2 via the b-catenin/LEF-1/TCF
gene target program (Fig. S2A). Since Notch-1 and Notch-2 have
been shown to have redundant roles in the intestine [2] a potential
dysregulation of Notch-2 through disrupted Wnt signaling could be
of importance in the development and progression of CRC.
Contrasting this, Chu et al. [28] found that Notch-2 expression may
play a role in tumor inhibition in CRC where Notch-2 protein and
mRNA levels were found to be decreased and that high levels
correlates with differentiation of colon cancer cells. Recent
evidence shows that overactive Notch signaling is an important
early event in human colorectal carcinogenesis where the pathway
is overactivated in cancer-initiating cells and early adenomas
[32,55,56] compared to a lower activity in more advanced or
metastatic CRCs [29]. It is therefore not unlikely that Notch-2 is
deleted in advanced cancer stages but still plays an important role
in tumor formation. Notch-1 lacks putative LEF-1/TCF consensus
sites in the proximal promoter, where Notch-2 contains four LEF-
1/TCF sites, which may suggest a direct canonical Wnt-dependent
regulation of Notch-2 mRNA levels.
We therefore asked whether canonical Wnt signaling could
increase the Notch-2 promoter activity. HT29 cells are hard to
transfect and we therefore used a similar cell line, HCT116, which
instead of inactive Apc contains a mutated and constitutively
active b-catenin gene. Luciferase assays indicate an increased
activity for N2PR 22327/299 upon co-transfection with mutated
b-catenin, Tcf-4 or Lef-1 (Fig. 5A). N2PR 2110 only responded to
b-catenin and the results from the site-directed mutagenesis imply
that b-catenin affect the Notch-2 core promoter via non-canonical
Wnt signaling. It is previously known that b-catenin can interact
directly with NICD [45,47,48] and that Notch-1 is autoregulated in
mouse lymphocytes [57]. The proximal Notch-2 promoter
investigated in this study also contains two RBP-Jk-sites, indicating
a potential autoregulatory mechanism similar to Notch-1 regula-
tion. In a preliminary study N2ICD but not N1ICD was found to
overactivate the Notch-2 promoter in a luciferase assay (unpub-
lished data). Speculatively, b-catenin may interact with N2ICD to
potentiate the expression of Notch-2, but more studies are needed
to outline this interaction. Contrasting this, EMSA assays
suggested binding of Lef-1 to the 2110 LEF-1/TCF-site (Fig. 2),
which also could be verified with immunoprecipitation where, in
addition to recombinant Lef-1, recombinant Tcf-4 also success-
fully precipitated this part of the promoter region (Fig. 5C). This
might suggest that Tcf-4 or Lef-1 have the ability to bind the
promoter region where site 2110 is located if the conditions are
satisfied. However if this is the site for interaction between Wnt
signaling and Notch-2 in CRC is uncertain, and likely a larger part
of the promoter, and thereby the additional binding sites suggested
by the in silico and EMSA analyzes, are needed.
Both Tcf-4 and Tcf-1 are expressed in the intestinal mucosa
[58], while the cells in the crypts of colon express only Tcf-4 [7,59].
Lef-1 is normally not expressed in the intestinal tract but expression
has been detected in CRC and several CRC cell lines, together
with Tcf-4 and Tcf-1 [7,58]. This suggests that alterations on
several levels in the canonical Wnt pathway may contribute to
overactive Notch signaling, possibly both through mutational
inactivation of Apc and/or overexpression of other components in
the Wnt pathway.
Briefly, we also studied whether the Wnt pathway (i.e b-catenin)
was transcriptionally regulated by the NICD/Rbp-jk complex,
and thereby indicating a regulatory feed-back loop, through b-
catenin. By c-secretase treatment all Notch signaling is effectively
inhibited and in our experiments the well-known Notch target
gene Hes-1 [60], was almost completely downregulated (Fig. S4).
Previous studies, have established Wnt/b-catenin signaling as a
negative target of Notch signaling, e.g. through upregulation of
Sfrp1, Sfrp5, Dkk1, which are known to encode inhibitors of the
Wnt pathway [43,61–63]. In our HT29 cell line model,
preliminary results cannot confirm that b-catenin is a Notch
target in CRC cells since we do not see any effects on b-catenin or
its target cyclin D1 by DAPT treatment (blocking of intracellular
Notch signaling) (Fig. S4A and B). These results are in close
agreement with a study by Fre et al. [16] where the expression of
Tcf-4 and Lef-1 were found to be unaffected by Notch pathway
activation in mouse intestine, further indicating Notch-indepen-
dent activation of canonical Wnt signaling. Also, if b-catenin had
been negatively regulated by Notch in the intestinal tract,
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polyps. Active Notch signaling, however, clearly acts oncogenically
in this context where Notch inhibition can lead to goblet cell
formation and a decreased number of polyps [29,64].
In conclusion, in this paper we identify several potential target
genes of Wnt/b-catenin signaling among genes traditionally
classified as belonging to the Notch pathway. Analysis of the
genetic networks directly involved in Notch and Wnt signaling
suggests functional overlap and direct crosstalk via target gene
activation. More specifically, we suggest that Notch-2 is a novel
target, activated by Wnt signaling in colon cancer cells.
Materials and Methods
In silico identification of LEF-1/TCF-sites in Notch
pathway gene promoters
Identification of potential promoter regions and putative LEF-
1/TCF-sites therein was performed with Genomatix software
(http://www.genomatix.de, Genomatix Software GmbH, Mu-
nich, Germany) [33]. The Gene2Promoter software (Models:
library Vertebrate_Modules Version 4.5) was used to retrieve and
identify promoters approximately within 2500 bp upstream the
first exon of each retrieved gene (complete list is available on
request). The highest quality sequence obtained was then used in
the MatInspector software (MatInspector Release professional
7.7.3) to search and identify putative transcription factor binding
sites [65]. PromoterInspector (Genomatix) was used to verify the
transcriptional start site (TSS) in the Notch-2 promoter identified
with Gene2Promoter.
The Matrix Family Library Version 7.0 (October 2007) was
used and the selected groups were ALL vertebrates.lib where the
standard (0.75) core similarity and the optimized matrix similarity
was used.
Plasmids, constructs and cloning of the core and
proximal Notch-2 promoter
Full length murine Lef-1 (mLef-1) and human Tcf-4 (hTcf-4)
expressed in pCDNA6 were kind gifts from professor B.O
Williams while HA-S33Y-b-catenin, expressed in pCGN, was a
kind gift from professor Avri Ben-Ze’ev (via professor Anita
Sjo ¨lander).
For in vitro translation experiments HA-S33Y-b-catenin was
subcloned into pCDNA3 (Invitrogen, Cambridge, UK) using XbaI
and BamHI restriction enzymes.
A larger Notch-2 luciferase promoter reporter construct (N2PR
22327/299) (numbering relative to translational start site),
covering all four LEF-1/TCF-sites in the Notch-2 promoter, was
constructed using primers:
N2PR 22327/299-forward:5 9-GGTACCTGGGGATTAATA-
GGCTGTGG-39
N2PR 22327/299-reverse:5 9- CTCGAGCTCCTGCTTCA-
AAGGCTCAG-39,
as well as a smaller (N2PR 2110) covering the most proximal
LEF-1/TCF-site using primers:
N2PR 2110-forward:5 9-GGTACCGTTGCACACCCGA-
GAAAGTT-39
N2PR 2110-reverse:5 9- CTCGAGATCTTCTCGGTCGC-
CTCCT-39.
Forward primers were designed with an additional KpnI
restriction site and reverse primers with a XhoI restriction site.
PCR-products were cloned into the pGEM-T vector (Promega)
according to manufacturer’s conditions and then further cloned
into pGL3 luciferase reporter (Promega, Wisconsin, USA)
containing a TATA-box (described previously [40]) or pGL3-
basic (Promega) using KpnI and XhoI.
Site-directed mutagenesis of 2110 LEF1/TCF site in the Notch-2
promoter
The plasmid pGL3-basic-N2PR 2110 was used as the parental
clone for the mutagenesis experiment. A mutation in the 2110
LEF1/TCF site was generated by replacing the site with a SpeI-
restriction site. Briefly, two PCR-amplicons were generated, the
first using primers:
N2PR 2110 SpeI-forward:5 9-AGGAACTAGTAGCAGGAG-
GAGGGGAGGA-39 (containing the SpeI restriction sequence)
and the pGL3-specific primer
GLprimer2: 59-CTTTATGTTTTTGGCGTCTTCCA-39,a n d
the second using the pGL3-specific primer RVprimer3: 59-
CTAGCAAAATAGGCTGTCCC-39 and N2PR 2110 SpeI-reverse:
59-CTCGAGGCTAGC ACTAGT GCTCAGGCCCTGGCGC-
TA-39 (containing the SpeI restriction sequence), with pGL3-TATA-
N2PR 2110 as a template. Amplicons were separately cloned into
the pGEM-T vector and sequentially transferred into pGL3-TATA
using KpnI, XhoI and SpeI restriction enzymes thereby mutating the
2110 LEF1/TCF core sequence CTTTGA into ACTAGT.
In vitro translation and electrophoretic mobility-shift
assay (EMSA)
In vitro translated proteins were prepared with the TNTH
coupled reticulocyte lysate system (Promega). For protein-DNA
binding interaction studies, in vitro translated Lef-1 and b-catenin
were incubated with the following
32P-labeled duplex oligonucle-
otide probe CD1TOP (59-CTCTGCCGGGCTTTGATCTT-
TGCTTAACAACA-39). The binding reaction contained 50 fmol
of
32P-labeled probe that was incubated for 30 min with the in vitro
translated proteins in 10 mM Hepes/70 mM KCl/1 mM dithio-
treitol/1 mM EDTA/7.5 mM MgCl2/4% (vol/vol) glycerol/
8 mg/ml salmon sperm DNA. For competition experiments, 300
-or 900-fold excess unlabeled double-stranded oligonucleotides
(Probes sequences are found in Table S1), used as competitors,
were incubated with the extracts at room temperature 10 min
prior to probe addition. Bound complexes were separated on 6%
polyacrylamide gels, dried and visualized on X-ray film. TNTH
coupled reticulocyte lysate without in vitro translated proteins was
used as a negative control.
Cell cultivation
HCT116 and HT29 colon cancer cells (ATCC, Manassas, VA,
USA) were cultivated in McCoy’s 5A media (Gibco/Invitrogen)
supplemented with 10% foetal bovine serum at 37uCi n5 %C O 2.
Twenty-four hours prior to transfection or chromatin immuno-
precipitation, the cells were split with 0.05% Trypsin-EDTA
(Gibco/Invitrogen) and counted.
ZnCl2-induction of wild-type (wt) Apc in HT29. HT29
cells harbouring a vector carrying the wt-Apc gene (HT29-APC) or
the control gene b-galactosidase (HT29-b-galactosidase), regulated
by a zinc inducible promoter (generous gift from professor B.
Vogelstein) were cultivated as described above, with the exception
that cells were selectively grown by the addition of 1.2%
hygromycine B (Invitrogen). Twenty-four hours before harvest,
the cells were split with 0.05% Trypsin-EDTA and counted.
HT29-APC and HT29-b-gal. were seeded in MULTIWELL
TM 6
well (Falcon, BD Bioscience, San Jose, CA) (1,0610
6/well) and
100 mM ZnCl2 was added to the medium in the interval of 24, 18,
12, 6, 3 and 0 hours before cell harvest and RNA as well as protein
isolation.
siRNA treatment of HT29 cells. Cells for siRNA
transfection were seeded in MULTIWELL
TM 12 well (Falcon)
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5/well), as described above. A pool of four different siRNA
oligonucleotides targeting b-catenin mRNA (siGENOME
SMARTpool
TM, Dharmacon, Chicago, IL, USA) with the
sequence: GAUCCUAGCUAUCGUUCUU, UAAUGAGGAC-
CUAUACUUA, GCGUUUGGCUGAACCAUCA, GGUAC-
GAGCUGCUAUGUUC, were transfected into HT29 with
DharmaFECT4
TM transfection reagent (Dharmacon) according
to the manufacturer’s recommendations. The final siRNA
concentration was 100 nM. As control experiment, cells were in
parallel mock transfected with siGLOH transfection indicator
(Dharmacon) only or a non-specific siRNA pool (siCONTROL
TM
Non-Targeting siRNA pool, Dharmacon).
RNA and protein isolation
RNA and protein was isolated with the PARIS
TM Kit (Ambion
Inc., Austin, TX, USA) according to the supplier’s recommenda-
tions. The protein concentration was spectrophotometrically
measured using Bradford Reagent (Sigma, St. Louis, USA).
Briefly, 2 mL sample was mixed with 98 uL Milli-Q H2O and
1 mL Bradford Reagent. As standard curve 0/1/2/4/8 1 mg/mL
BSA (Sigma) was mixed with Milli-Q H2O to a final volume of
100 mL and then 1 mL Bradford reagent was added. The samples
were immediately vortexed and 200 mL sample was added to an
ELIZA plate and measured by THERMOmax microplate reader
(Molecular Devices) with SOFTMAX software (Molecular Devic-
es). All measurements were performed in duplicates.
cDNA synthesis and semi-quantitative RT-PCR
200 ng total RNA from each sample was reversely transcribed
into cDNA with SuperScript
TMIII (Invitrogen) according to the
supplier’s recommendation. To determine the expression of Apc
or silencing of b-catenin, the well-established target gene of an
active Wnt pathway, cyclin D1, was used as a positive control [9].
As negative controls and controls for equal loading the
endogenous genes Gapdh was used. For quantitative assessments,
the mRNA expression was normalized against Gapdh.1 mLo f
cDNA solution was added to 19 mL of a standard master mix
containing 0.5 units of ThermoWhite DNA Polymerase (Saveen
Werner AB, Limhamn, Sweden) and 1 mM of the appropriate
primers (Supplemental Information S1 for primer sequences and
PCR-conditions). Separation of the PCR products was achived in
1.5% agarose gels and detection with ethidium bromide and UV-
light. The software Quantity One (Bio-Rad Laboratories,
Hercules, CA, USA) was used for semi-quantitative densiometric
analysis.
Western blot
Cell lysates containing equal amounts of total protein were
denatured in NuPAGEH LDS Sample Buffer (Invitrogen) at 70uC
for 10 min with NuPAGEH Sample Reducing Agent (Invitrogen).
The proteins were separated at 200 V for 35 min in NuPAGEH 4–
12% Bis-tris gels (Invitrogen) held in NuPAGEH MES DS
Running Buffer (206) diluted 1:20 with H2O, 0.25% NuPAGEH
Antioxidant (Invitrogen) was added to the inner chamber. After
the separation, the proteins were blotted to PVDF membranes
(Pierce, Rockford, IL, USA) at 30 V for 60 min in NuPAGEH
Transfer Buffer (206) (Invitrogen) diluted 1:20 in H2O with 20%
methanol and 0.1% NuPAGEH Antioxidant. The PVDF mem-
branes were blocked with 5% Blotto (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA) dissolved in Tris-buffered saline with
0.1% TweenH- 20 (TBS-T) (Sigma) for 60 min at room
temperature. The primary antibodies added to the PVDF
membranes were diluted in TBS-T as follows: anti-APC 1:500
(Abcam, Cambridge, UK), anti-b-catenin 1:1000 (Millipore Corp.,
Mosheim, France), anti-Gapdh 1:2000 (Millipore), anti-Notch-2
1:2000 (Santa Cruz) and anti-His (66His tagH antibody) 1:1000
(Abcam). The antibodies were incubated for 60 min at room
temperature or over night in 4uC, washed in TBS-T, followed by
incubation for 60 min at room temperature with appropriate
secondary antibodies, goat-anti-mouse 1:10000 (Jackson Immu-
noResearch Europe Ltd., Suffolk, UK) and goat-anti-rabbit
1:10000 (Cayman Chemical, Ann Arbor, MI, USA). The PVDF
membranes were exposed to ECL Western Blotting Substrate
(Pierce) and photographed digitally. Before reincubation of the
membranes, the antibodies were stripped with Restore
TM Western
Blot Stripping Buffer (Thermo SCIENTIFIC, Rockford, IL, USA)
for 15 min at room temperature and washed in TBS-T.
Animals and handling of tumor specimens
C57BL/6 mice with the APC
Min/+ genotype (The Jackson
Laboratory, Bar Harbor, ME, USA) were used in the present
study Animals were housed in ventilated cages at 2361uC with a
12-h light/dark cycle. Standard diet (CRME rodent, Special Diet
Services Ltd., Witham, Essex, UK) and water were available ad
libitum. DNA for genotyping was isolated from tail biopsies with the
Extract-N-Amp Tissue PCR Kit
TM (Sigma), according to
supplier’s recommendations. The Apc encoding gene were
genotyped as previously described [66]. All experimental proce-
dures were approved by the animal Care and Use Committee at
the Linko ¨ping University (Permit Number: 44-06).
Tumors and non-tumor intestinal mucosa specimens were
collected and handled as previously described [67]. mRNA
expression of mNotch-1, mNotch-2 and mHes-1 was subsequently
determined with the 7500 Fast Real-Time PCR System (Applied
Biosystems, Foster City, CA, USA), using predesigned primer/
probe assays purchased from Applied Biosystems (sequences
available at request). Ct values were related to the endogenous
control gene GAPDH (DCt), and relative expression (2
2DCt) was
normalised to the average expression in non-tumor intestinal
mucosa of APC
Min/+mPGES-1
+/+ mice (2
2DDCt).
Luciferase reporter assay
24 hours prior to luciferase reporter assays, HCT116 or HT29
cells were seeded and co-transfected with 200 ng reporter vector
(pGL3-TATA with and without N2PR 22327/299 or 2110
insert), 95 ng pSV-b-galactosidase and 455 ng pCGN-HA-S33Y-
b-catenin, pcDNA6-mLef-1 or pcDNA6-hTcf-4, using Lipofecta-
mine LTXH according to supplier’s recommendations. Controls
were co-transfected with empty pCDNA6 vector and 24 h post
transfection both luciferase and b-galactosidase activities were
measured. As a background control, pGL3-TATA without insert
was used and treated as described above. The luciferase activity
was determined by the ratio of luciferase to b-galactosidase activity
and the relative activity by the ratio of promoter activity vs.
background control.
Chromatin immunoprecipitation
To investigate binding of LEF-1/TCF-family members Lef-1
and Tcf-4 to Notch-2 LEF-1/TCF-site 2110, chromatin immuno-
precipitation (ChIP) assays were carried out using a ChIP Assay
Kit (Millipore). Briefly, 2.5610
5 HCT116 cells/well were seeded
in MULTIWELL
TM 6 well (Falcon) and co-transfected with
200 ng pGL3-TATA-N2PR 22327/299, 200 ng pGL3-TATA-
N2PR 2110 and either 2.1 mg6 6histidine tagged pcDNA6-hTcf-
4 or pcDNA6-mLef-1, respectively, using Lipofectamine LTX
(Invitrogen). 48 h post transfection, cells were fixed with 1%
formaldehyde for 10 minutes and washed twice in ice-cold
phosphate-buffered saline. Cells were lysed in sodium dodecyl
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50 mM Tris-HCl [pH 8.0]) containing protease inhibitors, and
DNA in the cross-linked chromatin preparations was sonicated to
an average fragment size of 0.2–1.0 kb using a Bioruptor
TM
(Diagenode, NJ, USA) and 14 pulses for 30 seconds sonication
followed by 30 seconds of rest. The insoluble material was
removed by centrifugation, and soluble chromatin samples were
precleared with a 50% slurry of protein A-Sepharose-salmon
sperm DNA. Each sample was incubated overnight at 4uC with
5 mg of rabbit polyclonal antibodies 66His tagH antibody - ChIP
Grade (Abcam). As a negative isotype control, Normal rabbit IgG
(Millipore) was used. Immune complexes were collected with
protein A-Sepharose and eluted. Input templates were purified
from 5% of the original lysates in parallel with the eluted
immunoprecipitated samples. Cross-linking was reversed by
incubation at 65uC for 4 h in 200 mM NaCl. After phenol-
chloroform extraction and ethanol precipitation, the recovered
DNA (2 ml from immunoprecipitated chromatin DNA samples or
2 ml from the input DNA control) was subjected to PCR
amplification with the following primers:
N2PR 2110 ChIP forward:5 9- GGGGAGTCGAGGCATTTG -39
N2PR 2110 ChIP reverse:5 9- AGGAGCCCCACTCTCTCCT -39.
As a negative control 170 bp of the NCAPD2 (non-SMC
condensin I complex, subunit D2) were amplified using primers:
NCAPD2 ChIP forward:5 9-ATGGTTGCCACTGGGGATCT-39
NCAPD2 ChIP reverse:5 9-TGCCAAAGCCTAGGGGAAGA-39.
Statistic, graphs and image handling
All statistics and graphs are computed in GraphPad Prism 5
(GraphPad Software Inc., San Diego, CA, USA) or SPSS v15.0
(SPSS UK Ltd, Woking, UK). Group comparisons for the in vitro
luciferase assays were performed using Independent sample t-tests
and error bars describe the standard error of the mean (SEM).
Differences in mRNA levels between mouse adenomas and
normal murine intestinal tissue were analyzed with the Mann-
Whitney U-test (non-normal distributed data) and error bars
describe the interquartile range. Figure composition and adjust-
ments in whole image contrast levels were performed in Adobe
Photoshop CS4.
Supporting Information
Figure S1 Competitive electro mobility-shift assay
reveals binding of in vitro translated b-catenin/Lef-1 to
Notch pathway gene promoters. Duplex CD1TOP probes
were ‘‘end labeled’’ with [
32P]dATP, incubated with in vitro
translated Lef-1/b-catenin and exposed to competition with
abundance of cold duplex oligonucleotides (6300 and 6900,
respectively). The protein-DNA complexes were separated by
electrophoresis and visualized by autoradiography. As a compe-
tition control cold CD1TOP and cold mutated CD1FOP
competed with radiolabeled CD1TOP and to confirm that
radioactive labeled CD1TOP binds Lef-1 specifically, plasmid-
free reticulocyte lysate were subjected to in vitro translation and
incubated with radiolabeled probe. Competition of cold and –cold
mutated Jagged-1 21933, 21635, 21083, 2238, Maml-1 2746,
2698, 21864 and Hes-1 2528, 2568, 2476, Positive competitor
control, plasmid free reticulocyte lysate, Notch-2 22261, 2869,
2689, 2110, Rfng 22481, Numb 2342, Lfng 22128, 21513,
21291, 21023 and Numbl 22587, 22480 and 21919. Number-
ing of putative LEF-1/TCF-sites is relative to each gene’s
translational start site.
(TIF)
Figure S2 Notch pathway gene expression following
RNAi silencing of b-catenin in HT29 cells. Gene expression
was normalized against the negative control Gapdh. The expression
is presented 0–96 h post transfection. (A) The expression of Cyclin
D1, Gapdh, Hes-1, Hes-7, Notch-2, Maml-1, Lfng, Rfng, Numb land
Numb. (B) The protein expression of b-catenin (,88 kDa) and
loading control, Gapdh, 0–96 h post transfection of anti-b-
catenin-siRNA.
(TIF)
Figure S3 b-catenin and cyclin D1 expression remain
unaffected in DAPT treated HT29 cells. HT29 cells were
treated with 12.5 mM of the c-secretase inhibitor DAPT for 24 h
thereby inhibiting Notch signaling. (A) Western blots with Hes-1
and b-catenin antibodies on HT29 whole-cell lysate following 24 h
DAPT treatment. Gapdh was used as a loading control. (B) The
expression of cyclin D1 was semi-quantitatively determined in
DAPT treated HT29-cells. Semi-quantitative RT-PCR was
carried out on cDNA reversely transcribed from 200 ng total
RNA. Bars describe the relative expression of cyclin D1 in HT29
normalized against Gapdh expression.
(TIF)
Figure S4 HT29 cells were co-transfected with pGL3-TATA
carrying N2PR -110 (or empty pGL3-TATA) and HA-S33Y-b-
c a t e n i ni np C G Na sw e l la sp S V - b-galactosidase control vector (n=6).
(TIF)
Table S1
(XLS)
Supplemental Information S1
(DOC)
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